KR-1-2

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameKR-1-2

Drug Alias Name11-beta-hydroxysteroid dehydrogenase type 1 inhibitor (type 2 diabetes/glaucoma/dementia), Korea Research Institute of Chemical TechnologyKR-1-2, Korea Research Institute of Chemical Technology11-beta-HSD1 inhibitor (type 2 diabetes/glaucoma/dementia), Korea Research Institute of Chemical Technology

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors

Targets11-beta-hydroxysteroid dehydrogenase

Therapy Area/IndicationsDiabetes Mellitus, Type 2GlaucomaDementia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKorea Research Institute Of Chemical Technology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKorea Research Institute Of Chemical Technology

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2GlaucomaDementia

Other Information

ATC CodeN/A